These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 2731990)
1. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Flegel WA; Wölpl A; Männel DN; Northoff H Infect Immun; 1989 Jul; 57(7):2237-45. PubMed ID: 2731990 [TBL] [Abstract][Full Text] [Related]
2. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Flegel WA; Baumstark MW; Weinstock C; Berg A; Northoff H Infect Immun; 1993 Dec; 61(12):5140-6. PubMed ID: 8225591 [TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor. Chen AR; McKinnon KP; Koren HS J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966 [TBL] [Abstract][Full Text] [Related]
4. The role of lipoproteins in inactivation of endotoxin by serum. Northoff H; Flegel WA; Yurttas R; Weinstock C Beitr Infusionsther; 1992; 30():195-7. PubMed ID: 1284705 [TBL] [Abstract][Full Text] [Related]
5. The role of lipoproteins in the inactivation of endotoxin by serum. Northoff H; Flegel WA; Yurttas R; Weinstock C Infusionsther Transfusionsmed; 1992 Aug; 19(4):202-3. PubMed ID: 1422080 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a CD14- and serum-independent pathway in the induction of endotoxin-tolerance in human monocytes and THP-1 monocytic cells. Heagy W; Hansen C; Nieman K; West MA Shock; 2003 Apr; 19(4):321-7. PubMed ID: 12688542 [TBL] [Abstract][Full Text] [Related]
7. Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide. Ulmer AJ; Feist W; Heine H; Kirikae T; Kirikae F; Kusumoto S; Kusama T; Brade H; Schade U; Rietschel ET Infect Immun; 1992 Dec; 60(12):5145-52. PubMed ID: 1280625 [TBL] [Abstract][Full Text] [Related]
8. Role for circulating lipoproteins in protection from endotoxin toxicity. Feingold KR; Funk JL; Moser AH; Shigenaga JK; Rapp JH; Grunfeld C Infect Immun; 1995 May; 63(5):2041-6. PubMed ID: 7729918 [TBL] [Abstract][Full Text] [Related]
9. Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor. Warren HS; Riveau GR; de Deckker FA; Chedid LA Infect Immun; 1988 Jan; 56(1):204-12. PubMed ID: 3275583 [TBL] [Abstract][Full Text] [Related]
10. Lipoproteins do not modulate the tissue factor activity, plasminogen activator or tumour necrosis factor production induced by lipopolysaccharide stimulation of human monocytes. Schlichting E; Henriksen T; Lyberg T Scand J Clin Lab Invest; 1994 Oct; 54(6):465-73. PubMed ID: 7809580 [TBL] [Abstract][Full Text] [Related]
11. Bacillus Calmette-Guérin potentiates monocyte responses to lipopolysaccharide-induced tumor necrosis factor and interleukin-1, but not interleukin-6 in bladder cancer patients. Conti P; Reale M; Nicolai M; Barbacane RC; Placido FC; Iantorno R; Tenaglia R Cancer Immunol Immunother; 1994 Jun; 38(6):365-71. PubMed ID: 8205557 [TBL] [Abstract][Full Text] [Related]
12. Endogenous lipoproteins impact the response to endotoxin in humans. Harris HW; Johnson JA; Wigmore SJ Crit Care Med; 2002 Jan; 30(1):23-31. PubMed ID: 11902267 [TBL] [Abstract][Full Text] [Related]
13. Glucose kinetics in rats infused with endotoxin-induced monokines or tumor necrosis factor. Bagby GJ; Lang CH; Hargrove DM; Thompson JJ; Wilson LA; Spitzer JJ Circ Shock; 1988 Feb; 24(2):111-21. PubMed ID: 3370760 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686 [TBL] [Abstract][Full Text] [Related]
15. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. Brandtzaeg P; Osnes L; Ovstebø R; Joø GB; Westvik AB; Kierulf P J Exp Med; 1996 Jul; 184(1):51-60. PubMed ID: 8691149 [TBL] [Abstract][Full Text] [Related]
16. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. Sellati TJ; Bouis DA; Kitchens RL; Darveau RP; Pugin J; Ulevitch RJ; Gangloff SC; Goyert SM; Norgard MV; Radolf JD J Immunol; 1998 Jun; 160(11):5455-64. PubMed ID: 9605148 [TBL] [Abstract][Full Text] [Related]
17. The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Read TE; Harris HW; Grunfeld C; Feingold KR; Kane JP; Rapp JH Eur Heart J; 1993 Dec; 14 Suppl K():125-9. PubMed ID: 8131781 [TBL] [Abstract][Full Text] [Related]